 Connection
George Wang to Cannabinoid Receptor Agonists
This is a "connection" page, showing publications George Wang has written about Cannabinoid Receptor Agonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.324 |
|
|
|
-
Wang GS, Buttorff C, Wilks A, Schwam D, Tung GJ, Banerji S, Dart RC, Pacula RL. Comparison of hospital claims and poison center data to evaluate health impact of opioids, cannabis and synthetic cannabinoids. Am J Emerg Med. 2022 Mar; 53:150-153.
Score: 0.178
-
Buttorff C, Wang GS, Wilks A, Tung G, Kress A, Schwam D, Pacula RL. Impact of Recreational Cannabis Legalization on Opioid Prescribing and Opioid-Related Hospital Visits in Colorado: an Observational Study. J Gen Intern Med. 2023 09; 38(12):2726-2733.
Score: 0.049
-
Kosnett MJ, Ma M, Dooley G, Wang GS, Friedman K, Brown T, Henthorn TK, Brooks-Russell A. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):355-362.
Score: 0.049
-
Rague JM, Ma M, Dooley G, Wang GS, Friedman K, Henthorn TK, Brooks-Russell A, Kosnett MJ. The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):363-369.
Score: 0.048
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|